Clinical Trial Results The clinical trial SURMOUNT-5 (NCT05822830) of adults with obesity who did not have type 2 diabetes demonstrated that Zepbound patients had an average weight loss of 50.3 lbs (22.8 kg), which was 20.2% of their body weight, and a 7.2-inch ( 18.4 cm) reduction in waist circumference, at 72 weeks
Habits between appointments A daily Lifestyle Score, streaks, and check-ins build protein, hydration, fiber, and movement into your routine so the habits keep going between prescriber visits
In the case of a severe and progressive condition with acute exacerbations, treatments may be administered every few days for best results
Yes, it works in much the same way as the weekly injections
(Basics & Mechanism) GLP-1 receptor agonists are a type of medication that mimics a natural hormone in the body called glucagon-like peptide-1, or GLP-1
At Southern Care Anesthetics, our team closely monitors patients using BPC-157 for bone healing, ensuring that the treatment is providing optimal results